Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Effectiveness of Adding the Health Promotion and Rehabilitation for Treatment for Alcohol and Drug Abusers (VIP)
This study is currently recruiting participants.
Verified October 2011 by Skane University Hospital
Study NCT01414907   Information provided by Skane University Hospital

First Received on August 9, 2011.   Last Updated on October 9, 2011   History of Changes

August 9, 2011
October 9, 2011
October 2010
May 2013   (final data collection date for primary outcome measure)
Change from abuser to non-abuser [ Time Frame: 6 weeks, 3, 6, 9, 12 and 24 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01414907 on ClinicalTrials.gov Archive Site
  • Health status [ Time Frame: 6 weeks, 3, 6, 9, 12 and 24 months ] [ Designated as safety issue: No ]
  • Quality of life [ Time Frame: 6 weeks, 3,6,9,12 and 24 months ] [ Designated as safety issue: No ]
  • Harm reduction [ Time Frame: 6 weeks, 3,6,9,12 and 24 months ] [ Designated as safety issue: No ]
  • Cost-effectiveness [ Time Frame: 24 months ] [ Designated as safety issue: No ]
Same as current
 
 
 
Study of Effectiveness of Adding the Health Promotion and Rehabilitation for Treatment for Alcohol and Drug Abusers
VIP (Very Important Patient) Project on Alcohol and Drug Abusers - RCT of Efficacy of the Adding the Health Promotion and Rehabilitation for Treatment of Alcohol and Drug Abusers

The purpose of this study is to evaluate the effect of adding the Health Promotion activities and rehabilitation to the usual alcohol and drug interventions on the outcome for alcohol and drug abusers compared to the usual intervention alone.

Background: Alcohol and drug abuse are followed by tremendous physical, psychological and social problems as well as early death. Heavy smoking, poor nutrition, physical inactivity and chronic diseases (co-morbidity) are often part of these problems and illnesses.

There seems to be a large potential for a better outcome by including smoking cessation, physical training, diet and nutrition as well as co-morbidity in a multi-disciplinary setting - a potential not used yet. This Very Integrated Program (VIP) is inspired from the rehabilitation offered to patients with chronic diseases and surgical patients having a likewise unhealthy lifestyle and similar co-morbidity.

Aim: to evaluate the effect of adding the VIP program to the usual alcohol and drug intervention on the outcome for alcohol and drug abusers compared to the usual intervention alone.

The VIP project consists of 3 steps:

  1. To map the health status and estimate the potential improvement for 400 alcohol and drug abusers
  2. To pilot test the VIP program
  3. To evaluate it compared to the daily routines for 260 alcohol and drug abusers with a poor health status in a randomised controlled trial.

Main outcome: Change from abuser to non-abuser. Secondary outcomes are health status; quality of life, use of health services, time return to work (or similar activity level), harm reduction, and cost-effectiveness.

Interventional
 
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
  • Alcoholism
  • Substance-Related Disorders
  • Smoking
  • Chronic Disease
  • Malnutrition
Behavioral: Health promotion activities
Counselled activities on tobacco smoking secession, diet correlation and physical activities
Other Names:
  • smoking secession
  • physical activity
  • diet
Health Promotion activities
Intervention: Behavioral: Health promotion activities
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
260
December 2015
May 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • alcohol or drug dependency

Exclusion Criteria:

  • withdrawal of informed consent
  • missing competence to give informed consent
  • pregnant or lactating women
Both
18 Years and older
No
Contact: Hanne Tønnesen, MD, PhD 0046 (0) 40 33 29 85 hanne.tonnesen@med.lu.se
Contact: Johanna Adami, MD, PhD 0046 (0) 8 473 3076 Johanna.Adami@ki.se
Sweden
 
NCT01414907
VIP-LU-2011
No
Hanne Tønnesen, Lund University
Skane University Hospital
  • Swedish Council for Working Life and Social Research
  • The Swedish Council for Information on Alcohol and Other Drugs
  • Lund University
  • Copenhagen University Hospital, Denmark
Principal Investigator: Hanne Tønnesen, MD, PhD WHO-CC, Bispebjerg University Hopital, Copenhagen, Denmark
Skane University Hospital
October 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP